[1] 刘 皓,刘秉文.载脂蛋白C研究进展[J].中国动脉硬化杂志,2002,10(1):76-80. [2] 高 纯,周 新.载脂蛋白CⅡ研究进展[J].国际检验医学杂志,2002,1(6):285-286. [3] Havel R J,Fielding C J,Olivecrona T,et al.Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources[J].Biochem,1973,12(9):1828-1833. [4] Bjorkegren J,Karpe F,Milne R W,et al.Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma[J].J Lipid Res,1998,39(7):1412-1420. [5] Curry M D,McConathy W J,Fesmire J D,et al.Quantitative determination of apolipoproteins C-Ⅰ and C-Ⅱ in human plasma by separate electroimmunoassays[J].Clin Chem,1981,27:543-548. [6] Connelly P W,Maguire G F,Hofmann T,et al.Structure of apolipoprotein C-ⅡToronto,a nonfunctional human apolipoprotein[J].Proc Natl Acad Sci USA,1987,84(1):270-273. [7] Zdunek J,Martinez G V,Schleucher J,et al.Global structure and dynamics of human apolipoprotein CⅡ in complex with micelles:Evidence for increased mobility of the helix involved in the activation of lipoprotein lipase[J].Biochem,2003,42:1872-1889. [8] Andersson Y,Majd Z,Lefebvre A M,et al.Developmental and pharmacological regulation of apolipoprotein C-Ⅱ gene expression.Comparison with ApoC-Ⅰ and ApoC-Ⅲ gene regulation[J].Arterioscler Thromb Vasc Biol,1999,19:115-121. [9] Kei A A,Filippatos T D,Tsimihodimos V,et al.A review of the role of apolipoprotein C-Ⅱ in lipoprotein metabolism and cardiovascular disease[J].Metabolism,2012,61(7):906-921. [10] Myklebost O,Williamson B,Markham A F,et al.The isolation and characterization of cDNA clones for human apolipoprotein CⅡ[J].J Biol Chem,1984,259(7):4401-4404. [11] Vainio P,Virtanen J A,Kinnunen P K,et al.Action of lipoprotein lipase on mixed triacylglycerol/phosphatidylcholine monolayers.Activation by apolipoprotein C-Ⅱ[J].J Biol Chem,1983,258(9):5477-5482. [12] 陈 文,陈代文,黄艳群.脂蛋白脂酶(LPL)生理功能及特异表达[J].中国畜牧兽医,2004,31(4):29-30. [13] Goldberg I J,Merkel M.Lipoprotein lipase:Physiology,biochemistry,and molecular biology[J].Front Biosci,2001,6:D388-D405. [14] Mcllhargey T L,Yang Y Y,Wong H,et al.Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-Ⅱ-responsive lipolysis from lipoprotein lipase to hepatic lipase[J].J Biol Chem,2003,278(25):23027-23035. [15] Surendran R P,Visser M E,Heemelaar S,et al.Mutations in LPL,ApoCⅡ,APOA5,GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia[J].J Intern Med,2012,272(2):185-196. [16] Hoffer M J,van Eck M M,Havekes L M,et al.Structure and expression of the mouse apolipoprotein C2 gene[J].Genomics,1993,17(1):45-51. [17] Côté M,Provost P R,Gérard-Hudon M C,et al.Apolipoprotein C-Ⅱ and lipoprotein lipase show a temporal and geographic correlation with surfactant lipid synthesis in preparation for birth[J].BMC Dev Biol,2010,10:111. [18] Lenich C,Brecher P,Makrides S,et al.Apolipoprotein gene expression in the rabbit:Abundance,size,and distribution of apolipoprotein mRNA species in different tissues[J].J Lipid Res,1988,29(6):755-764. [19] Zannis V I,Cole F S,Jackson C L,et al.Distribution of apolipoprotein A-Ⅰ,C-Ⅱ,C-Ⅲ,and E mRNA in fetal human tissues.Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages[J].Biochem,1985,24(16):4450-4455. [20] Li Z,Du B,Li S,et al.Cloning and characterization of an apolipoprotein C2 promoter in the mouse central nervous system[J].Neural Regen Res,2013,8(2):156-161. [21] Takase S,Osuga J,Fujita H,et al.Apolipoprotein C-Ⅱ deficiency with no rare variant in the ApoC2 gene[J].J Atheroscler Thromb,2013,20(5):481-493. [22] Owen M R,Corstorphine C C,Zammit V A.Overt and latent activities of diacylglycerol acytransferase in rat liver microsomes:Possible roles in very-low-density lipoprotein triacylglycerol secretion[J].Biochem J,1997,323(1):17-21. [23] Amazaki T,Sasaki E,Kakinuma C,et al.Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1[J].J Biol chem,2005,280(22):21506-21514. [24] Di Filippo M,Marèais C,Charrière S,et al.Post-heparin LPL activity measurement using VLDL as a substrate:A new robust method for routineassessment of plasma triglyceride lipolysis defects[J].PLoS One,2014,9(6):e99721. [25] 徐 凯,王效京,刘 宏,等.过氧化物酶体增殖物激活受体α在猪肝脏组织中发育性表达研究[J].中国畜牧兽医,2014,41(10):178-182. [26] Araki S,Okazaki M,Goto S.Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids[J].Gerontology,2004,50:206-215. [27] Sasaki N,Holdsworth G,Barnhart R L,et al.Effect of a high carbohydrate diet on the content of apolipoproteins C-Ⅱ,C-Ⅲ and E in human plasma high density lipoprotein[J].Atherosclerosis,1983,46(3):341-352. |